Patterns of cancer care costs in a country with detailed individual data

Medical Care
Tony BlakelyPhilip Clarke

Abstract

To determine health system expenditure on cancers by time since diagnosis using data for an entire country. New Zealand cancer registry data was linked to hospitalization, pharmaceutical, outpatient, general practice, laboratory, and other datasets, with costs ascribed to each event occurring in 2006-2011. "Excess" cancer costs were estimated by subtracting "expected costs" for citizens without cancer from the "total cost" for cancer patients ($2011 inflation-adjusted). Gamma regressions were used to estimate costs per person-month. For first adult cancer diagnosed that the excess cost per person was between US$3400 and US$4300 in the first month postdiagnosis (varied by sex and age), fell to US$50-US$150 per month at 2 or more years postdiagnosis (excluding those within a year of death), but increased again if dying from their cancer (US$3800-US$8300 in the last month of life). Such patterns varied by cancer, for example, in the first month postdiagnosis for 65 year olds it varied 20-fold from US$800 for prostate to US$15,900 for brain cancer. Per diagnosed case, total excess costs varied from US$5000 (melanoma) to US$66,000 (bone and connective tissue) [Corrected]. Excess cancer costs made up 6.5% of total Vote:Health expendi...Continue Reading

References

Jan 1, 1997·Annual Review of Public Health·J S Preisser, G G Koch
Mar 29, 2001·Annual Review of Public Health·M L BrownC Snyder
Aug 21, 2002·Medical Care·Martin L BrownRuth Etzioni
Dec 26, 2003·Statistics in Medicine·Paul W DickmanTimo Hakulinen
Oct 30, 2007·Nature Clinical Practice. Oncology·K Robin YabroffMartin L Brown
Jun 19, 2009·Medical Care·Joseph LipscombK Robin Yabroff
Jun 19, 2009·Medical Care·William E Barlow
Feb 10, 2010·International Journal of Epidemiology·Diana SarfatiNeil Pearce
Mar 12, 2010·The American Journal of Clinical Nutrition·Sarah F BrennanJayne V Woodside
Jan 7, 2011·Health Economics·Pieter H M van BaalWerner B F Brouwer
Jan 14, 2011·Journal of the National Cancer Institute·Angela B MariottoMartin L Brown
May 27, 2011·The New England Journal of Medicine·Thomas J Smith, Bruce E Hillner
Oct 6, 2012·Mayo Clinic Proceedings·Mustaqeem Siddiqui, S Vincent Rajkumar
Jan 5, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Bengt Jönsson
Jun 5, 2013·Australian and New Zealand Journal of Public Health·Roy CostillaTony Blakely

❮ Previous
Next ❯

Citations

Sep 20, 2015·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Larissa SchwarzkopfRudolf Maria Huber
Jul 31, 2018·PloS One·David E GoldsburyDianne L O'Connell
Nov 9, 2015·PharmacoEconomics·Paula K LorgellyUNKNOWN Cancer 2015 Investigators
Apr 14, 2016·British Journal of Cancer·Mauro LaudicellaPeter C Smith
May 21, 2019·Journal of Oncology Practice·Jason HuAlice Dragomir
Oct 21, 2016·BMC Cancer·Claire de OliveiraMurray D Krahn
Oct 8, 2016·BMC Health Services Research·Virginia BecerraUNKNOWN Multicentric Spanish Group of Clinically Localized Prostate Cancer
Sep 12, 2015·Health Affairs·Ryan Callahan, Ara Darzi
Aug 6, 2019·Climacteric : the Journal of the International Menopause Society·E FelettoK Canfell
Jan 13, 2021·International Journal of Environmental Research and Public Health·Anna GigliStefano Guzzinati
Jul 31, 2021·The Lancet. Gastroenterology & Hepatology·Maarten J IJzerman
Jul 31, 2021·The Lancet. Gastroenterology & Hepatology·Raymond Hugo HendersonMark Lawler
Jul 28, 2021·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Susanna BuscoSilvia Francisci

❮ Previous
Next ❯

Software Mentioned

HealthTracker
Proc
Genmod SAS

Related Concepts

Related Feeds

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.